“FREQUENCY AND CHARACTERISTICS OF ADVERSE EVENTS ASSOCIATED WITH ANTI-TUBERCULOSIS DRUGS DURING THE TREATMENT OF DRUG-RESISTANT PULMONARY TUBERCULOSIS”. Eureka Journal of Health Sciences & Medical Innovation, vol. 2, no. 6, June 2026, pp. 1-11, https://eurekaoa.com/index.php/5/article/view/1148.